Press Releases

Mithra Signs LSA for Commercialization of Estelle® and Myring™ in Israel
20 August 2019
EN FR

Mithra obtains crucial additional Estelle® patent in Japan
8 August 2019
EN FR

Mithra CDMO Strengthens its Management Team and Accelerates Key R&D Programs
16 July 2019
EN FR

Mithra Signs LSA for Commercialization of Myring™ in Germany, the biggest market in Europe
28 May 2019
EN FR

Tibelia®, First Tibolone-Based Hormone Therapy Approved in Canada
15 May 2019
EN FR

Information on the Total Number of Voting Rights (Denominator)
29 April 2019
EN FR

Mithra Signs License and Supply Agreement for Commercialization of Myring™ in Latin and South America
25 April 2019
EN FR

Mithra announces new agreement with GSP for development of an additional injectable
18 April 2019
EN FR

Mithra Releases 2018 Annual Report and Invitation to its Ordinary General Shareholders’ Meeting
8 April 2019
EN FR

Annual Report 2018
8 April 2019
EN FR

Mithra wins essenscia Innovation Award 2019 for its new generation contraceptive pill, Estelle®
2 April 2019
EN FR

Mithra receives Orphan Drug Designation from FDA for E4 in neonatal encephalopathy treatment
2 April 2019
EN FR